With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor

WITH FDA NOD, NS PHARMA DUCHENNE DRUG BECOMES SAREPTA COMPETITOR

Duchenne muscular dystrophy patients whose disease is characterized by a particular genetic mutation now have a new treatment option...

Perceptive Advisors' LianBio Inks Deals With BridgeBio, MyoKardia

PERCEPTIVE ADVISORS' LIANBIO INKS DEALS WITH BRIDGEBIO, MYOKARDIA

Two California biotechs have teamed up with LianBio, a new company launched earlier this week by hedge fund Perceptive Advisors, as...

 
 
 
F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections

F2G LANDS $60M FOR A NEW TACK ON TAKING OUT RARE FUNGAL INFECTIONS

Fungal infections might not immediately come to mind as rare diseases, but growing resistance to older drugs means that patients who...

Pfizer's Bourla: There's Coronavirus Vaccine Pressure, But It's Not Political

PFIZER'S BOURLA: THERE'S CORONAVIRUS VACCINE PRESSURE, BUT IT'S NOT POLITICAL

Pfizer Inc. CEO Albert Bourla said he doesn't worry about political pressure to bring potentially the first coronavirus vaccine to...

 
 
 
Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup

LIGAND TO SPEND $438M TO ADD PROTEIN MAKER PFENEX TO TECHNOLOGY LINEUP

Ligand Pharmaceuticals plans to acquire recombinant protein therapeutics maker Pfenex for $438 million, the companies announced Monday....

 
 
 
Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials

ROCHE GUT DISEASE DRUG PRODUCES MIXED RESULTS IN LATE-STAGE TRIALS

Results from four studies within a major Roche-run clinical trials program of an investigational gut disease drug have muddled the...

Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3

SERES SETS SIGHTS ON FDA AFTER C. DIFF MICROBIOME THERAPY SCORES IN PHASE 3

An experimental Seres Therapeutics capsule of live bacteria has met the goals of a pivotal study evaluating it as a treatment for a...

 
 
 
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

ABBVIE EXITS EDITAS ALLIANCE, PRUNING ANOTHER GENETIC MEDICINES PACT

AbbVie has terminated a research partnership with Editas Medicines, returning to the biotech rights to an experimental gene-editing...

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

FDA GREEN-LIGHTS ROCHE SPINAL MUSCULAR ATROPHY DRUG, FIRST ORAL THERAPY

The FDA on Friday approved a new spinal muscular atrophy drug that patients can take at home. Risdiplam is a liquid medicine intended...

 
 
 
Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare

MODERNA, PFIZER PROTOCOLS MAY MAKE COVID VACCINES HARD TO COMPARE

It will be difficult to compare Moderna, Inc. and Pfizer Inc.'s coronavirus vaccines based on their Phase 3 study designs, some vaccines...

Bio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More

BIO ROUNDUP: A TELEHEALTH COMBO, FDA'S BCMA OK, BIOGEN'S BET & MORE

The novel coronavirus has driven the pharmaceutical industry to upend its research priorities. Big Pharma companies are focusing on...

 
 
 
GlaxoSmithKline Multiple Myeloma Drug Earns FDA's First Anti-BCMA Nod

GLAXOSMITHKLINE MULTIPLE MYELOMA DRUG EARNS FDA'S FIRST ANTI-BCMA NOD

Patients with advanced multiple myeloma have a new treatment option with the FDA's approval of a GlaxoSmithKline drug that targets...

G1 Vets Launch Arc Therapeutics to Take on New Cancer Target

G1 VETS LAUNCH ARC THERAPEUTICS TO TAKE ON NEW CANCER TARGET

Three early employees of G1 Therapeutics have launched a new oncology-focused company and raised $6 million to move a preclinical program...

 
 
 
Biogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds

BIOGEN TO PAY DENALI $1B TO PARTNER ON PARKINSON'S DRUG & OTHER NEURO MEDS

Denali Therapeutics has selected a brain-penetrating Parkinson's disease drug candidate to advance to late-stage testing and Biogen...

As Patients Pivot to Telehealth, Teladoc & Livongo Plan $18.5B Tie-Up

AS PATIENTS PIVOT TO TELEHEALTH, TELADOC & LIVONGO PLAN $18.5B TIE-UP

Telemedicine giant Teladoc Health is buying health technology company Livongo Health in an $18.5 billion cash and stock deal that comes...

 
 
 
 
 
 
CymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage

CYMABAY PBC DRUG HITS PHASE 3 GOALS WITH SIGNS OF SIDE EFFECT ADVANTAGE

CymaBay Therapeutics' investigational drug seladelpar succeeded in a late-stage trial in patients with primary biliary cholangitis...

Still Stuck on Adhesion Issues, FDA Rejects DBV's Peanut Allergy Patch

STILL STUCK ON ADHESION ISSUES, FDA REJECTS DBV'S PEANUT ALLERGY PATCH

A skin patch developed by DBV Technologies to desensitize peanut allergy sufferers to the allergen over time has been rejected by the...

 
 
 



World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

How COVID-19 Arose and Amplified Along the Meat Supply Chain

How COVID-19 Arose and Amplified Along the Meat Supply Chain

Early in this unforgettable year, a wet market in Wuhan, China, emerged as a possible step along the way, if not the place of origin, of the outbreak that would seed the... Read more ...

Global Methane Emissions Soaring, But How Much Was Due to Wetlands?

Global Methane Emissions Soaring, But How Much Was Due to Wetlands?

Infographic published with permission from the authors of “Increasing anthropogenic methane emissions arise equally from agricultural and fossil fuel sources.” (Credit: Jackson... Read more ...

Computer System Assurance: A Paradigm Shift Away from Compliance to Quality

Computer System Assurance: A Paradigm Shift Away from Compliance to Quality

Our Professional Services Written by: Gary E. Ritchie, MS, Senior Validation Engineer Consultant, PSC Biotech Corporation The FDA will release the draft guidance on Computer... Read more ...

With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor

With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor

Duchenne muscular dystrophy patients whose disease is characterized by a particular genetic mutation now have a new treatment option following the FDA's Wednesday approval of a... Read more ...

Perceptive Advisors' LianBio Inks Deals With BridgeBio, MyoKardia

Perceptive Advisors' LianBio Inks Deals With BridgeBio, MyoKardia

Two California biotechs have teamed up with LianBio, a new company launched earlier this week by hedge fund Perceptive Advisors, as part of deals that expand their reach into... Read more ...

F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections

F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections

Fungal infections might not immediately come to mind as rare diseases, but growing resistance to older drugs means that patients who develop these infections have limited... Read more ...

Calliditas gets controlling stake, option to buy out Genkyotex and its...

Calliditas gets controlling stake, option to buy out Genkyotex and its failed PBC drug badams Fri, 08/14/2020 - 05:07 Read more ...

17β-Estradiol affects the innate immune response in common carp

Abstract Inflammation is the evolutionary conserved immune response to harmful stimuli such as pathogens or damaged cells. This multistep process acts by removing injurious... Read more ...

Chutes & Ladders-WuXi taps veteran operations head Dong to lead new vaccines...

Chutes & Ladders-WuXi taps veteran operations head Dong to lead new vaccines unit kblankenship Fri, 08/14/2020 - 08:23 Read more ...

Team discovers a new role for a well-known molecule as a plant hormone

Researchers at the University of Maryland have discovered an entirely new role for a well-known plant molecule called ACC, providing the first clear example of ACC acting on... Read more ...